HDFC Pharma and Healthcare Fund-Reg(G)
- Equity
- Sector Funds
- Very High Risk
Fund Overview
- Assets Under Management (AUM)
- ₹2,611.33 Cr
- Expense Ratio
- 1.97%
- Riskometer
- Very High
- Category
- Sector Funds
- Asset Type
- Equity
- Benchmark
- NIFTY 50 - TRI
- SIP
- Available
- Switch
- Available
- Inception Date
- 13 Sept 2023
- ISIN
- INF179KC1HL7
- Scheme Code
- HPRGR
- Fund Scheme ID
- 37971
Thinking of investing in mutual funds?
Discover a simpler way to begin investing with Indipe.
Performance & Returns
Calculate SIP ReturnsReturns by period
| Period | Trailing Return | Absolute Return | Annualised Return | CAGR |
|---|---|---|---|---|
| 1 Month | 2.07% | 2.07% | 24.32% | 36.70% |
| 3 Months | 11.69% | 11.69% | 46.40% | 63.09% |
| 6 Months | 24.94% | 24.94% | 49.47% | 50.70% |
| 1 Year | 25.51% | 25.51% | 25.51% | 27.47% |
| Since Inception | 30.42% | 117.19% | 40.13% | 30.54% |
Past performance is not indicative of future returns.
Portfolio
Asset Allocation
100.00%
- Domestic Equities97.23%
- Cash & Cash Equivalents and Net Assets2.77%
Top Sectors
- Healthcare96.70%
- Miscellaneous3.32%
- Trading0.53%
Holdings
Overview of fund allocations across sectors and securities
Healthcare
Value
₹2,525.16 Cr
Weightage
96.70%
Miscellaneous
Value
₹86.70 Cr
Weightage
3.32%
Trading
Value
₹13.84 Cr
Weightage
0.53%
About
Fund Manager(s)
Mr. Nikhil Mathur
Launch Date
13 Sept 2023
Benchmark
NIFTY 50 - TRI
Objective
To provide long-term capital appreciation by investing predominantly in equity and equity related securities of Pharma and healthcare companies.
RISKOMETER
The riskometer indicates the level of risk associated with the fund based on historical data and portfolio composition.
Exit Load, Stamp Duty and Tax Implication
- Exit load
- 1% on or before 30D, Nil after 30D
- Stamp duty on investment: 0.005% (from July 1st, 2020)
- from July 1st 2020
- Tax implication
- --
Loading related funds
